...
首页> 外文期刊>Iranian Journal of Pathology >A Comparative Evaluation of ELISA, PCR, and Serum Agglutination Tests For Diagnosis of Brucella Using Human Serum
【24h】

A Comparative Evaluation of ELISA, PCR, and Serum Agglutination Tests For Diagnosis of Brucella Using Human Serum

机译:ELISA,PCR和血清凝集试验对人血清布鲁氏菌病诊断的比较评价

获取原文
           

摘要

Background & Objective : Since the symptoms of Brucellosis are often atypical and nonspecific, using clinical signs alone to diagnose brucellosis is not advised; therefore, the diagnosis relies predominantly on laboratory testing. Currently, molecular, serological, and microbiological methods are used for diagnosis of this disease. In this study we examined ELISA, PCR and serum agglutination (SAT) methods on human patient serum samples. Methods: A total of 100 serum samples were collected from suspected patients. Fifty serum samples gave a positive result with the Wright test. The ELISA method was first employed on all samples for the detection of IgG and IgM antibodies against Brucella. Subsequently, the rapid PCR methodology was used to identify presence of Brucella genome in 500 μL of each serum sample. The B4/B5 primer pair was used for PCR? amplification. Results: Out of the 100 serum samples obtained from patients with suspected brucellosis, 50 samples tested positive by SAT and displayed high titers of 1/160. Of these 50 positive samples, 49 samples were positive as per the ELISA test whereas one sample tested negative. The PCR test was conducted on all 100 serum samples and results showed that the 45 serum samples that gave a positive agglutination test were also positive by PCR. Conclusions: Various laboratory methods have beenused or introduced for the detection of Brucella. Molecular methods such as PCR, a rapid and sensitive method for detection of bacteria, have also been reported. Based on the results of this study, we propose that the simultaneous use of serology and molecular techniques has the potential to overcome limitations of detection thereby enabling the selection of appropriate treatment for the patient.
机译:背景与目的:由于布鲁氏菌病的症状通常是非典型且非特异性的,因此不建议仅使用临床体征来诊断布鲁氏菌病。因此,诊断主要取决于实验室测试。当前,分子,血清学和微生物学方法用于诊断该疾病。在这项研究中,我们检查了人类患者血清样品的ELISA,PCR和血清凝集(SAT)方法。方法:从疑似患者中收集了100份血清样本。 50份血清样品在赖特试验中给出阳性结果。 ELISA方法首先用于所有样品,以检测针对布鲁氏菌的IgG和IgM抗体。随后,快速PCR方法用于鉴定500μL每个血清样品中布鲁氏菌基因组的存在。 B4 / B5引物对用于PCR?放大。结果:从疑似布鲁氏菌病患者获得的100份血清样本中,有50份通过SAT检测呈阳性,并显示高滴度为1/160。根据ELISA测试,在这50个阳性样品中,有49个样品呈阳性,而一个样品则呈阴性。对所有100个血清样品进行了PCR试验,结果表明,凝集试验呈阳性的45个血清样品也通过PCR呈阳性。结论:已经使用或引入了多种实验室方法来检测布鲁氏菌。也已经报道了诸如PCR的分子方法,其是一种快速,灵敏的细菌检测方法。根据这项研究的结果,我们建议同时使用血清学和分子技术有可能克服检测的局限性,从而能够为患者选择合适的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号